Skip to main navigation Skip to search Skip to main content

Pyridoxine-dependent Epilepsy With Elevated Urinary alpha-Amino Adipic Semialdehyde in Molybdenum Cofactor Deficiency

  • E.A. Struijs
  • , B. Nota
  • , A. Bakkali
  • , S. Al Shahwan
  • , G.S. Salomons
  • , B. Tabarki

    Research output: Contribution to Journal › Article › Academic › peer-review

    Abstract

    α-Amino adipic semialdehyde (α-AASA) accumulates in body fluids from patients with pyridoxine-dependent epilepsy because of mutations in antiquitin (ALDH7A1) and serves as the biomarker for this condition. We have recently found that the urinary excretion of α-AASA was also increased in molybdenum cofactor and sulfite oxidase deficiencies. The seizures in pyridoxine-dependent epilepsy are caused by lowered cerebral levels of pyridoxal-5-phosphate (PLP), the bioactive form of pyridoxine (vitamin B
    Original languageEnglish
    Pages (from-to)e1716-e1719
    JournalPediatrics
    Volume130
    Issue number6
    DOIs
    Publication statusPublished - 2012

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Pyridoxine-dependent Epilepsy With Elevated Urinary alpha-Amino Adipic Semialdehyde in Molybdenum Cofactor Deficiency'. Together they form a unique fingerprint.

    Cite this